 | Up a level |
Macdonald, RL.; Kassell, NF.; Mayer, S.; Ruefenacht, D.; Schmiedek, P.; Weidauer, S.; Frey, A.; Roux, S.; Pasqualin, A.; Raabe, A. (2008). Clazosentan to overcome neuroslogical ischemia and infarction occurring after subarachnoid hermorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke, 39(11), pp. 3015-3021. Baltimore, Md.: Lippincott Williams & Wilkins 10.1161/STROKEAHA.108.519942
